BRETT BOND: Open Payments
NPI 1194425033 · HOPKINSVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,672 in 87 payments from 9 companies in 2025. Trend: 2023 $2,454 · 2024 $2,382 · 2025 $1,672
Food & beverage: $1,672
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 19 | $374 |
| Otsuka America Pharmaceutical, Inc. | 9 | $260 |
| Neurocrine BioSciences, Inc. | 6 | $250 |
| Lundbeck LLC | 14 | $248 |
| ABBVIE INC. | 24 | $241 |
| Vanda Pharmaceuticals Inc. | 9 | $191 |
| Janssen Pharmaceuticals, Inc | 4 | $68 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $24 |
| Alkermes, Inc. | 1 | $17 |
Products named: COBENFY, ABILIFY ASIMTUFII, INGREZZA, VRAYLAR, FANAPT, ABILIFY MAINTENA, INVEGA SUSTENNA, REXULTI.
Industry payments across KY — which companies pay providers there.
